Endometrial Neoplasms: all 1,347 studies
Page 10 of 14. Open to participants first (452), then studies with results posted, then the rest; newest registration first within each.
- Pembrolizumab With Ataluren in Patients With Metastatic pMMR and dMMR Colorectal Carcinoma or Metastatic dMMR Endometrial Carcinoma: the ATAPEMBRO StudyStatus unknownNCT04014530Phase 1/2
- Multi-omics Study on the Pathogenesis of Malignant Transformation of AdenomyosisStatus unknownNCT04010487
- A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid TumorActive, not recruitingNCT04008797Phase 1/2
- Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.Active, not recruitingNCT03983954Phase 1
- Evaluation of the Adhesion to the GENEPY NetworkStatus unknownNCT03979612
- CT Assessment of BMI in Endometrial Cancer PatientsCompletedNCT03962140
- TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial CancerActive, not recruitingNCT03955978Phase 1
- Durvalumab and Olaparib in Metastatic or Recurrent Endometrial CancerStatus unknownNCT03951415Phase 2
- Diagnostic Performance of Hybrid PET/MRI in the Staging of Endometrial CarcinomaSuspendedNCT03945786
- Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial CancerActive, not recruitingNCT03935256Phase 2
- Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial CancerActive, not recruitingNCT03932409Phase 1
- Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube CancersTerminatedNCT03924245Phase 1
- Correlation Between Hysteroscopic Diagnosis of Endometrial Hyperplasia and Histopathological ExaminationCompletedNCT03917147
- the Effectiveness of a Weight Management Program in Patients Who Have Completed Treatment for Endometrial CancerCompletedNCT03908996Not applicable
- Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological CancerWithdrawnNCT03902379Not applicable
- Cervical and Endometrial Injection for Sentinel Lymph Node Detection in Endometrial CancerCompletedNCT03900104Not applicable
- Multimedia Aid Gynecologic Counseling and ConsentCompletedNCT03899441Not applicable
- Endometrial Changes in Breast Cancer Women With or Without Hormonal TherapiesCompletedNCT03898947
- Neoadjuvant Celecoxib in Newly Diagnosed Patients With Endometrial CarcinomaStatus unknownNCT03896113Phase 2
- The Clinical Significance of Sentinel Lymph Node Imaging Combined With Imaging Examination in Pelvic and Peritoneal Lymphadenectomy for Endometrial CarcinomaStatus unknownNCT03877627Not applicable
- Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced CancerActive, not recruitingNCT03860272Phase 1
- A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid TumorsCompletedNCT03849469Phase 1
- An Individualised and Patient-centred Follow-up Program for Women With Gynaecological CancerStatus unknownNCT03838861Not applicable
- Sentinel Node Detection in Endometrial Cancer: A Consolidation Study on Detection Rates of Metastatic DiseaseStatus unknownNCT03838055Not applicable
- Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial CancerWithdrawnNCT03836157Phase 2
- Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological TumorsStatus unknownNCT03827837Phase 2
- Urinary miRNA in Endometrial Cancer StudyCompletedNCT03824613
- The Multicentic Trial in Fertility-sparing Treatment and Ovarian Preservation Management for Early Endometrial CancerStatus unknownNCT03804463Not applicable
- Sentinel Lymph Node Mapping In Endometrial CancerStatus unknownNCT03778255Not applicable
- Exploring the Potential of Novel Biomarkers Based on Plasma microRNAs for a Better Management of Pelvic Gynecologic TumorsActive, not recruitingNCT03776630Not applicable
- Characterization of the Genetic Profile of Type 2 Endometrial Carcinoma in MartiniqueCompletedNCT03766672
- Application of Tachosil During LymphadenectomyCompletedNCT03752606Phase 4
- A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)CompletedNCT03752398Phase 1
- Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial CancersCompletedNCT03748186Phase 1
- A Phase 1 Study of [225Ac]-FPI-1434 InjectionTerminatedNCT03746431Phase 1
- UTOLA: UTerin OLAparibCompletedNCT03745950Phase 2
- MSI in Circulatory DNA of Endometrial CancerStatus unknownNCT03744962
- Evaluation of the Efficacy for Sentinel Lymph Node Policy in High-risk Endometrial CarcinomaCompletedNCT03716414
- Total Laparoscopic Hysterectomy Versus Total Abdominal Hysterectomy in Women With Endometrial NeoplasiaCompletedNCT03698604Not applicable
- Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial CancerTerminatedNCT03694834Early Phase 1
- Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid TumorsActive, not recruitingNCT03682289Phase 2
- Evaluation of the Efficacy for Sentinel Lymph Node Policy in Intermediate-risk Endometrial CarcinomasWithdrawnNCT03677024Not applicable
- COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.CompletedNCT03667716Phase 1
- High Intensity Interval Training (HIIT) for Patients With Cancer-related Lymphedema in the Lower LimbsCompletedNCT03653819Not applicable
- A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced MalignanciesCompletedNCT03629756Phase 1
- Comparison of the Effectiveness Metformin for Deceasing Proliferative Marker in Endometrial Cancer CellsCompletedNCT03618472Not applicable
- Sexual Rehabilitation Programme After Radiotherapy for Gynaecological CancerStatus unknownNCT03611517Not applicable
- Atezolizumab Trial in Endometrial Cancer - AtTEndCompletedNCT03603184Phase 3
- Exploring HIFU as a Treatment for Rectal and Other Pelvic CancersStatus unknownNCT03595722Not applicable
- Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT03586661Phase 1
- Cost-utility of Ambulatory Surgery in the Management of Endometrial Cancer(AMBU-ENDO)CompletedNCT03580421Not applicable
- PET/CT in the Management of Patients With Early Stage Endometrial CancerStatus unknownNCT03570866
- Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel?Status unknownNCT03570437Phase 2
- Fertility-sparing Management Using High-dose Oral Progestin in Young Women With Endometrial CancerStatus unknownNCT03567655Phase 2
- Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO]CompletedNCT03555422Phase 3
- Biomarkers for Diagnosis and Prognosis of Endometrial CarcinomaStatus unknownNCT03553589
- Effect of Fertility-sparing Therapy of Early Endometrial CancerStatus unknownNCT03538704Not applicable
- Phase II Study of Atezolizumab + Bevacizumab in Endometrial CancerActive, not recruitingNCT03526432Phase 2
- A Study of XmAb®20717 in Subjects With Selected Advanced Solid TumorsCompletedNCT03517488Phase 1
- Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal CarcinomatosisCompletedNCT03508570Phase 1
- Carboplatin, Paclitaxel With or Without Avelumab in Advanced or Recurrent Endometrial CancerStatus unknownNCT03503786Phase 2
- Identification and Characterization of Endometrial Cancer With Specific Tumor Markers in Serum and Endometrial TissueCompletedNCT03498924
- FESPET Study: Female EStrogen recePtor in Endometrial Cancer TreatmentStatus unknownNCT03489473
- PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial CancerActive, not recruitingNCT03469674Phase 3
- The Role of Hypoxia as a Selective Pressure for TP53 MutationsTerminatedNCT03466034
- Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized CareCompletedNCT03460483Not applicable
- HE4 is a Beneficial Biomarker in Endometrial CancerStatus unknownNCT03459976
- F-18 TFB-PET Studies in Cancer Patients Undergoing NIS-containing Viral TherapiesCompletedNCT03456908Phase 1
- Human Epididymis Protein 4 in Endometrial CarcinomaCompletedNCT03456791
- CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced CancersCompletedNCT03454451Phase 1
- Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer SurvivorsCompletedNCT03372720Not applicable
- Health and Recovery Program in Increasing Physical Activity Level in Stage IA-IIIA Endometrial Cancer SurvivorsCompletedNCT03367923Phase 2
- A Study to Assess the Efficacy and Safety of ABTL0812CompletedNCT03366480Phase 1/2
- Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers.Status unknownNCT03349463Phase 4
- Multiorgan Metabolic Imaging Response Assessment of AbemaciclibCompletedNCT03339843Phase 2
- Self-Advocacy Serious Game in Advanced CancerCompletedNCT03339765Not applicable
- Role of Senescence in the Development of Endometrial CancerStatus unknownNCT03338985Not applicable
- Patient's Experience and Choice Between Investigations for Endometrial Cancer in Postmenopausal BleedingCompletedNCT03330015
- VIrtual REality Glasses for the Enhancement of Acute BRACHYtherapy Tolerance for Endometrial Cancer Patients.TerminatedNCT03324958Not applicable
- Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic TestingStatus unknownNCT03322176
- A Study of Pembrolizumab in Combination With Epacadostat in Women With Recurrent/Metastatic Endometrial CarcinomaWithdrawnNCT03310567Phase 2
- Risk Scoring Model for Endometrial CancerStatus unknownNCT03298100
- Survival Outcomes of Uterine Malignancies in Chinese PopulationStatus unknownNCT03291275
- Study of Universal Screening for Lynch Syndrome in Chinese Patients of Endometrial CancerStatus unknownNCT03291106
- The French E3N Prospective Cohort StudyActive, not recruitingNCT03285230
- A Study of Ketogenic Diet in Newly Diagnosed Overweight or Obese Endometrial Cancer PatientsCompletedNCT03285152Not applicable
- Durvalumab, Tremelimumab + Radiotherapy in Gynecologic CancerTerminatedNCT03277482Phase 1
- Pembrolizumab in Combination With Doxorubicin in Advanced, Recurrent or Metastatic Endometrial CancerCompletedNCT03276013Phase 2
- Cognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT StudyCompletedNCT03270995Not applicable
- Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial CancerCompletedNCT03241914Phase 2/3
- Laser Treatment of Genito-urinary Syndrome in WomenWithdrawnNCT03238053Not applicable
- Motivational Interviewing to Increase Physical Activity Behaviour in Cancer PatientsCompletedNCT03210129Not applicable
- Can 3D Ultrasound be Used as an Alternative to MRI to Assess Myometrial Invasion in Endometrial Cancer?Status unknownNCT03207061Not applicable
- Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine CancerCompletedNCT03192059Phase 2
- Adjuvant Protontherapy of Cervical and Endometrial CarcinomasStatus unknownNCT03184350Not applicable
- Targeted Disruption to Cancer Metabolism and Growth Through Dietary Macronutrient ModificationCompletedNCT03171506Not applicable
- Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsActive, not recruitingNCT03170960Phase 1
- Scale Down for Endometrial CancerCompletedNCT03169023Not applicable
- SC-004 Alone or With ABBV-181 in Subjects With Epithelial Ovarian, Fallopian Tube, Primary Peritoneal and Endometrial CancersTerminatedNCT03138408Phase 1
- Compare the Performance of Targeted Biopsy Versus Aspiration Biopsy With a Pipette for the Diagnosis of Endometrial CancerWithdrawnNCT03115593Not applicable